Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer
Abstract
Conventional treatment fails to completely eliminate highly invasive breast cancer cells, and most surviving breast cancer cells tend to reproliferate and metastasize by forming vasculogenic mimicry (VM) channels. Thus, a type of targeted liposomes was developed by modification with arginine8–glycine–aspartic acid (R8GD) to encapsulate daunorubicin and emodin separately. A combination of the two targeted liposomes was then developed to destroy...
Paper Details
Title
Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer
Published Date
Sep 2, 2019
Journal
Volume
28
Issue
3
Pages
245 - 258
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History